Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 4 I, 1999, Pages 1342-1350

  Maier, Lisa A ^a   Raynolds, Mary V ^b   Young, David A ^b   Barker, Elizabeth A ^b   Newman, Lee S ^b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BERYLLIUM; DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ARTICLE; BERYLLIOSIS; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LUNG FUNCTION TEST; LUNG LAVAGE; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0032906574     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.4.9806106     Document Type: Article

References (41)

1. Maier, L. A., and L. S. Newman. 1998. Beryllium Disease: Environmental and Occupational Medicine. Lippincott-Raven, Philadelphia. 1017-1031.
2. Kreiss, K., M. M. Mroz, B. Zhen, J. W. Martyny, and L. S. Newman. 1993. Epidemiology of beryllium sensitization and disease in nuclear workers. Am. Rev. Respir. Dis. 148:985-991.
3. 3. Am. J. Ind. Med. 30:16-25.
4. Newman, L. S., and K. Kreiss. 1992. Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium. Am. Rev. Respir. Dis. 145:1212-1214.
5. Newman, L. S. 1996. Immunology, genetics and epidemiology of beryllium disease. Chest 109:40S-43S.
6. Newman, L. S., K. Kreiss, T. E. J. King, S. Seay, and P. A. Campbell. 1989. Pathologic and immunologic alterations in early stages of beryllium disease. Am. Rev. Respir. Dis. 139:1479-1486.
7. Newman, L. S., C. Bobka, B. Schumacher, E. Daniloff, B. Zhen, M. M. Mroz, and T. E. King. 1994. Compartmentalized immune response reflects clinical severity of beryllium disease. Am. J. Respir. Crit. Care Med. 150: 135-142.
8. Mroz, M. M., K. Kreiss, D. C. Lezotte, P. A. Campbell, and L. S. Newman. 1901. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J. Allergy Clin. Immunol. 88:54-60.
9. Richeldi, L., R. Sorrentino, and C. Saltini. 1993. HLA-DPβ1 glutamate 69: a genetic marker of beryllium disease. Science 262:242-244.
10. Richeldi, L., K. Kreiss, M. M. Mroz, H. Zhen, P. Tartoni, and C. Saltini. 1997. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am. J. Ind. Med. 32:337-340.
11. Stubbs, J., E. Argyris, C. Lee, D. Monos, and M. Rossman. 1996. Genetic markers in beryllium hypersensitivity. Chest 109:45S.
12. Newman, L. S., R. Orton, and K. Kreiss. 1992. Serum angiotensin converting enzyme activity in chronic beryllium disease. Am. Rev. Respir. Dis. 146:39-42.
13. Daníloff, E. M., D. A. Lynch, B. Bucher Bartelson, J. D. J. Newell, S. M. Bernstein, and L. S. Newman. 1997. Observer variation and relationship of computed tomography to severity of beryllium disease. Am. J. Respir. Crit. Care Med. 155:2047-2056.
14. Tinkle, S. S., L. A. Kittle, B. Schumacher, and L. S. Newman. 1997. Beryllium induces IL-2 and IFN-γ in berylliosis. J. Immunol. 158:518-526.
15. Tiret, L., B. Rigat, S. Viskis, C. Breda, P. Corvol, F. Cambien, and F. Soubrier. 1992. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACF levels. Am. J. Hum. Genet. 51:197-205.
16. Rigat, B., C. Hubert, F. Athene-Gales, F. Cambien, P. Corvol, and F. Soubrier. 1990. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86:1343-1346.
17. Furuya, K., E. Yamaguchi, A. Itoh, N. Hizawa, N. Ohnuma, J. Kojima, N. Kodama, and Y. Kawakami. 1996. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis. Thorax 51:777-780.
18. Tiret, L., A. Bonnardeaux, O. Poirer, S. Ricard, P. Marqaues-Vidal, A. Evans, D. Arveiler, G. Luc, F. Kee, P. Ducimetiere, F. Soubrier, and F. Cambien. 1994. Synergistic effects of the angiotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction. Lancet 344:910-913.
19. Marian, A. J., Q.-t. Yu, R. Workman, G. Greve, and R. Roberts. 1993. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 342:1085-1086.
20. Raynolds, M. V., M. R. Bristow, E. W. Bush, W. T. Abraham, B. D. Lowes, L. S. Zisman, C. S. Taft, and M. B. Perryman. 1993. Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 342:1073-1075.
21. Benessiano, J., B. Crestani, F. Mestari, W. Klouch, F. Neukrich, S. Hacien-Bey, G. Durand, and A. Michel. 1997. High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma. J. Allergy Clin. Immunol. 99:53-57.
22. Dudley, C. R. K., B. Keavney, I. M. Stratton, R. C. Turner, and P. J. Ratcliffe. 1995. U.K. prospective diabetes study XV: relationship of reninangiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int. 48:1907-1911.
23. Harden, P. N., C. Geddes, P. A. Rowe, J. H. McIlroy, R. S. C. Rodger, F. J. R. Junor, J. D. Briggs, J. M. C. Connell, and A. G. Jardine. 1995. Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 345:1540-1542.
24. Brilla, C. G., G. P. Reams, B. Maisch, and K. T. Weber. 1998. Reninangiotensin system and myocardial fibrosis in hypertension: regulation of the myocardial collagen matrix. Eur. Heart J. 14J:57-61.
25. Weinstock, J. V., M. N. Ehrnipreis, D. L. Boros, and J. B. Gee. 1981. Efffect of SQ 14255, an inhibitor of angiotensin I-converting enzyme on the granulomatous response to Schistosoma mansoni eggs in mice. J. Clin. Invest. 67:931-936.
26. International Labour Organization. 1980. Guidelines for the Use of ILO International Classification of Radiographs of Pneumoconiosis. International Labour Office Occupational Safety and Health Series, No. 22 (REV). Geneva, Switzerland.
27. Morris, A., R. Kanner, and R. Crapo, editors. 1984. Clinical Pulmonary Function Testing: A Manual of Uniform Laboratory Procedures. Intermountain Thoracic Society, Salt Lake City, UT.
28. Goldman, H., and B. MR. 1959. Respiratory function tests: normal values at medium altitudes and the prediction of normal results. Am. Rev. Tuberc. 79:457.
29. Ogilvie, C., R. Forster, W. Blakemore, and J. Morton. 1956. A standardized breath-holding technique for the clinical measurements of the diffusing capacity of the lung for carbon monoxide. J. Clin. Invest. 36: 1-17.
30. Crapo, R., and A. Morris. 1981. Standardized single breath normal values for carbon monoxide diffusing capacity. Am. Rev. Respir. Dis. 123: 185-189.
31. Willcox, M., A. Kervitsky, L. Watters, and T. J. King. 1988. Quantification of cells recovered by bronchoalveolar lavage: comparison of the cytocentrifuge preparations to the filter method. Am. Rev. Respir. Dis. 138:74-80.
32. Lindpaintner, K., M. A. Pfeffer, R. Kreuts, M. H. Stampfer, K. Grodstein, F. LaMotte, J. Buring, and C. H. Hennekens. 1995. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 332:706-711.
33. Marre, M., X. Jeunemaitre, Y. Gallois, G. Chatellier, C. Sert, L. Dusselier, Z. Kahal, L. Chaillous, S. Halimi, A. Muller, H. Sackmann, B. Bauduceau, F. Bled, P. Passa, and F. Alhene-Glass. 1997. Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complication in insulin-dependent diabetes. J. Clin. Invest. 99:1585-1595.
34. Lieberman, J., A. Nosal, L. A. Schlessner, and A. Sastre-Foken. 1979. Serum angiotensin-converting enzyme for the diagnosis and therapeutic evaluation of sarcoidosis. Am. Rev. Respir. Dis. 120:329-355.
35. Gilbert, S., D. S. Steinbrech, S. K. Landas, and G. W. Hunninghake. 1993. Amount of angiotensin-converting enzyme mRNA reflects the burden of granulomas in granulomatous lung disease. Am. Rev. Respir. Dis. 148:483-186.
36. Tomita, H., Y. Ina, Y. Suguira, S. Sato, H. Kawaguchi, M. Morashita, M. Yamamoto, and R. Ueda. 1997. Polymorphisms in the angiotensin-converting enzyme (ACF.) gene and sarcoidosis. Am. J. Respir. Crit. Care Med. 156:255-259.
37. Arbustini, E., M. Grasso, G. Leo, C. Tinelli, R. Fasani, M. Diegoli, N. Banchieri, A. Cipriani, M. Gorrini, G. Semenzato, and M. Luisetti. 1996. Polymorphism of angiotensin-converting enzyme gene in sarcoi dosis. Am. J. Respir. Crit. Care Med. 153:851-854.
38. Costerousse, O., J. Allegrini, M. Lopez, and F. Alhene-Glas. 1993. Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 290:33-40.
39. Parving, H.-H., P. Jacobsen, L. Tarnow, P. Rossing, L. Lecerf, O. Poirier, and F. Cambien. 1996. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study. B.M.J. 313:591-594.
40. Takada, Y., K. Hiwada, H. Akutsu, A. Hashimoto, and T. Kokubu. 1984. The immunocytochemical detection of angiotensin-converting enzyme in alveolar macrophages from patients with sarcoidosis. Lung 162: 317-323.
41. Silverstein, E., L. P. Pertsehuck, and J. Friedland. 1479. Immunofluorescent localisation of angiotensin converting enzyme in epitheliod and giant cells of sarcoidosis granulomas. Proc. Natl. Acad. Sci. U.S.A. 76: 6646-6648.